Stay Up to Date
Breaking News,
Updates, & More
Click Here to
Subscribe

Concurrent Chemotherapy with Reirradiation for Head and Neck Cancer

TON - Daily - Head and Neck Cancer

Concomitant chemotherapy with reirradiation offers a cure for select patients with recurrent head and neck cancer in a previously irradiated area. With the findings of 2-year survival in 25% of patients, the researchers noted the importance of choosing the correct patients for this therapy. Previous concurrent chemoradiotherapy was associated with poor survival outcomes. In addition, there was significant risk of sever toxicity, with 20% of patients experiencing treatment-related death.

 

The complete study is published online in the journal Cancer (http://onlinelibrary.wiley.com/doi/10.1002/cncr.26084/abstract).

Related Items
November 4, 2019 — Oncology News & Updates
Web Exclusives published on November 5, 2019 in Financial Toxicity, Head and Neck Cancer, Hematologic Cancers, In the News, Leukemia
Oral Cancer and Sex in the Era of HPV Infection
Meg Barbor, MPH
Web Exclusives published on October 28, 2019 in Head and Neck Cancer
Low Survival in Patients with Head and Neck Cancers Linked to Delays in Radiation Therapy After Surgery
Corbin Davis
TOP - August 2018, Vol 11, No 2 published on August 3, 2018 in Head and Neck Cancer
Low-Level Laser Therapy Reduces Pain in Patients with Head and Neck Cancer
Eric Allan, MD
Audiocasts published on July 22, 2016 in Head and Neck Cancer
Severe Oral Mucositis Less Frequent, Briefer, Less Severe with Use of GC4419
Carryn Anderson, MD
Audiocasts published on July 12, 2016 in Head and Neck Cancer
Low-Level Laser Therapy Reduces Pain in Patients with Head and Neck Cancer
Meg Barbor, MPH
TOP - May 2016, Vol 9, No 2 published on May 13, 2016 in Head and Neck Cancer
Severe Oral Mucositis Less Frequent, Briefer, Less Severe with Use of GC4419
Meg Barbor, MPH
TOP - May 2016, Vol 9, No 2 published on May 13, 2016 in Head and Neck Cancer
Prophylactic Gabapentin Linked to Weight Loss, Narcotic Dependency
Meg Barbor, MPH
TOP - May 2016, Vol 9, No 2 published on May 13, 2016 in Conference Correspondent, Head and Neck Cancer
Infrastructure Issues in the US Drug Supply: Where Did the Drugs Go?
Timothy G. Tyler, PharmD, FCSHP
Web Exclusives published on November 29, 2011 in Head and Neck Cancer
Biopsy of Sentinel Lymph Node Considered Safe and Effective in Head and Neck Melanomas
TON - Daily published on August 8, 2011 in Head and Neck Cancer
Last modified: September 8, 2015